Take a deeper dive

Webinar | Drug Development Considerations for Dermatology:
More Than Skin Deep

This webinar covers an introduction to topical drug development and other important clinical pharmacology considerations for products for dermatological conditions. Topically applied drugs often follow different requirements for pharmacokinetic (PK) assessment than drugs administered orally or intravenously. During the webinar, issues specific for topical drug development will be discussed including various requirements, such as the maximal usage trial (MuST) for a successful application.

At the end of this webinar attendees should have a better understanding of:

  • Why does formulation matter?
  • How to collect and interpret pharmacokinetics for topically applied products
  • Regulatory requirements and clinical pharmacology considerations

Meet the Speaker

Elizabeth (Betty) Hussey, Pharm.D.
Vice President, Clinical Pharmacology & Pharmacokinetics

Dr. Hussey has over 30 years of extensive leadership and experience in drug development, clinical development, clinical pharmacology, and pharmacokinetics across multiple therapeutic areas and all phases of development. Dr. Hussey’s primary therapeutic area experience includes dermatology, metabolic diseases, CNS (headaches), antivirals, and anti-infectives with focus on early proof-of-concept.

Explore Our Blog

When Should You Hire a Clinical Pharmacologist?

Because of the importance of clinical pharmacology to drug development, it is essential to consider the expertise of your product…

Read More
T cells around a cancer cell

CAR T-Cell Therapy Challenges to Development & Approval

Chimeric antigen receptor T-cell (CAR T) therapy is a revolutionary immunotherapy that uses cells from the patient’s immune system to…

Read More

What is a 505(b)(2)?

The 505(b)(2) New Drug Application (NDA) is a streamlined NDA process in which the applicant relies upon one or more…

Read More